Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery
GLP-1 receptor agonists and cardiovascular outcomes in type 2 diabetes: Frontiers in Endocrinology , 14 , 9889489
This is an opportunity for us to understand your unique background, including your medical history, lifestyle, and any challenges you may have faced in your weight loss efforts
Diarrhea and constipation: Both common, sometimes alternating
For a side-by-side comparison of how semaglutide stacks up against the other major GLP-1 option, our semaglutide vs tirzepatide side effects guide compares the safety profiles in detail
Some medications act on GLP-1 receptors only